Combination Therapy With Intravitreal Nesvacumab+Aflibercept in Diabetic Macular Edema: The Phase 2 RUBY Trial

Related

• 

  Complications or Are They: Why We Can NEVER Get Enough ReST

  Jeffrey S. Heier, MD

  Peter K. Kaiser, MD FASRS

  Geoffrey G. Emerson, MD, PhD, FASRS

  J. Michael Jumper, MD, FASRS

  Ehab N. ELRAYES, MD, PhD ,FASRS

  Daniel Simhaee, MD

  ASSAF DOTAN, MD

  Paul Hahn, MD, PhD, FASRS

  Philip J. Ferrone, MD, FASRS

  Annual Meeting Talks

  2018

• 

  Prospective Trial Comparing Ranibizumab Monthly to Treat and Extent With and Without Angiography-Guided Laser for DME

  John F. Payne, MD

  Updates from the Field

  2016

• 

  New Biosimilar Bevacizumab and Ranibizumab for Retinal Diseases

  Alay S. Banker, MD

  Annual Meeting Talks

  2018